Health
WHO reveals that Hepatitis may kill more people than malaria, TB, HIV combined
The World Health Organisation has raised the alarm that viral hepatitis could kill more people than malaria, tuberculosis, and HIV combined by 2040 if the current infection rate continues.
According to WHO, hepatitis causes liver damage and cancer and kills over a million people annually. Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths.
WHO made this known in a statement it issued as the global health body joined the rest of the world to celebrate the 2023 World Hepatitis Day, themed, “One life, one liver”.
The health organisation noted that while Hepatitis C could be cured, only 21 per cent of the people living with the infection are diagnosed and only 13 per cent have received curative treatment.
WHO added that only 10 per cent of people living with chronic hepatitis B are diagnosed, and only 2 per cent of those infected are receiving lifesaving medicine.
“Viral hepatitis could kill more people than malaria, tuberculosis, and HIV combined by 2040 if current infection trends continue.
“Hepatitis causes liver damage and cancer and kills over a million people annually. Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths. Hepatitis C can be cured; however, only 21% of people living with hepatitis C infection are diagnosed and only 13% have received curative treatment.
“Just 10 per cent of people living with chronic hepatitis B are diagnosed, and only 2per cent of those infected are receiving the lifesaving medicine.”
WHO emphasised the importance of protecting the liver against hepatitis for living a long, healthy life, saying, “Good liver health also benefits other vital organs – including the heart, b, rain, and kidneys – that rely on the liver to function.”
WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, stated that despite available preventive measures and treatment, many people are undiagnosed.
“Millions of people are living with undiagnosed and untreated hepatitis worldwide, even though we have better tools than ever to prevent, diagnose and treat it.
“WHO remains committed to supporting countries to expand the use of those tools, including increasingly cost-effective curative medication, to save lives and end hepatitis,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
To combat viral hepatitis, WHo called for global communities to ensure access to treatment for all pregnant women and vaccines for babies at birth.
“To reduce new infections and deaths from hepatitis B and C, countries must: ensure access to treatment for all pregnant women living with hepatitis B, provide hepatitis B vaccines for their babies at birth, diagnose 90% of people living with hepatitis B and/or hepatitis C, and provide treatment to 80% of all people diagnosed with hepatitis.
“They must also act to ensure optimal blood transfusion, safe injections, and harm reduction.
“The reduction of hepatitis B infections in children through vaccination is a key intervention to limit viral hepatitis infections overall. The target for hepatitis B incidence is the only Sustainable Development Goal health target that was met in 2020 and is on track for 2030.
“However, many countries in Africa do not have access to the birth dose hepatitis B vaccines. Gavi’s recent restart of its Vaccine Investment Strategy 2018 – which includes the birth dose hepatitis B vaccine – will jumpstart newborn vaccination programs in West and Central Africa, where mother-to-child hepatitis B transmission rates remain very high.
“To help eliminate mother-to-child transmission, WHO recommends that all pregnant women should be tested for hepatitis B during their pregnancy. If positive, they should receive treatment and vaccines should be provided to their newborns. However, a new WHO report shows that of the 64 countries with a policy, only 32 countries reported implementing activities to screen for and manage hepatitis B in antenatal clinics.
“For people who want to maintain liver health, WHO recommends hepatitis testing, treatment if diagnosed, and vaccination against hepatitis B. Reducing alcohol consumption, achieving a healthy weight, and managing diabetes or hypertension also benefit liver health,” WHO stated.
Health
NCDC : Rainy Season To Increase Cholera Outbreaks in Ten States
They are Adamawa, Enugu, Kaduna, Kogi, Niger, Osun, Oyo, Plateau, Taraba, and Kwara.
The Nigeria Centre for Disease Control (NCDC) says that raining and flooding will increase cholera outbreak in ten prone states.
They are Adamawa, Enugu, Kaduna, Kogi, Niger, Osun, Oyo, Plateau, Taraba, and Kwara.
NCDC, in a statement, yesterday, said the alarm followed flood predictions issued by the Federal Ministry of Environment and the Nigerian Meteorological Agency indicating that the aforementioned states would experience heavy rainfall and flooding between 13th and 17th April 2026.
NCDC noted that, already, cases of cholera are on the rise across the cholera-prone states, and that could simply be attributed to the rainy season, and flood that might have contaminated people’s sources of food and water.
It said: “Recent national surveillance data show increasing cholera activity across multiple states.
Flooding during this period can rapidly increase the risk of disease outbreaks due to contamination of drinking water sources, disruption of sanitation systems, and increased exposure of communities to unsafe environmental conditions.
Importantly, these risks are preventable with early action.”
Health
FG effects 20% tarrif slash on pharmaceutical products
Reacting to the development, the President of the Pharmaceutical Society of Nigeria (PSN), Ayuba-Tanko Ibrahim, described the tariff cut as a positive step but cautioned that the gains would depend on complementary policy actions.
the Federal Government had in a document dated April 1, 2026, by the Minister of Finance and Coordinating Minister of the Economy, Mr. Wale Edun, approved sweeping tariff adjustments across 127 product lines, including antimalarial medicaments now pegged at 20 percent, as part of efforts to stimulate growth and ease the cost of critical imports.
Reacting to the development, the President of the Pharmaceutical Society of Nigeria (PSN), Ayuba-Tanko Ibrahim, described the tariff cut as a positive step but cautioned that the gains would depend on complementary policy actions.
“A drop in duties on drugs and pharmaceutical products is quite laudable. In normal circumstances, this should signpost a drop in prices of these products and promote accessibility to drugs and healthcare, albeit legitimately.
“The PSN appreciates and commends the commitment of the federal government in the ensuing scenario,” he said.
Emphasising that more is needed to be done to sanitise the sector, Ibrahim said: “It is noteworthy that the federal government must do a little more in terms of regulation and control of drug matters in Nigeria.
‘’Government must see a need for urgent intervention with a template akin to an all-purpose special vehicle that can help fix fundamental issues pertaining to local manufacture and drug prices.
” There is also a need to support local content in Active Pharmaceutical Ingredients, APIs, and vaccines availability to increase the contribution of the pharmaceutical sector to national GDP, ’’ he said.
Health
Resident Doctors Suspend Strike, Ask Members to Resume on Wednesday
The Nigerian Association of Resident Doctors (NARD) has suspended its planned indefinite nationwide strike and directed all members to resume duties on Wednesday, April 8, 2026.
The decision was announced on Tuesday following successful last-minute engagements with the Federal Government and other stakeholders over the contentious suspension of the Professional Allowance Table (PAT) and other welfare issues.
NARD had earlier declared a total and comprehensive strike effective from 12:00 a.m. on Tuesday, April 7, protesting the government’s move to halt implementation of the revised allowance structure, unpaid promotion arrears, and other outstanding agreements.
In a statement, the association said the suspension was reached after productive discussions, though it issued a fresh ultimatum, warning of renewed industrial action if demands are not fully met by April 21, 2026.
Patients and healthcare facilities across the country, which had braced for disruption in services, are expected to see normal operations resume from Wednesday morning.
NARD urged its members to return to work promptly while maintaining that the core issues remain unresolved and will be reviewed at the next National Executive Council meeting.
The development brings temporary relief to the public health system amid ongoing concerns over doctor shortages and welfare in Nigerian teaching and specialist hospitals.
-
Business2 days agoFCCPC says didn’t ban MTN, Glo, Airtel data loans
-
News2 days agoJUST IN: Tinubu Signs ₦68.32 Trillion 2026 Budget
-
News2 days agoUTME 2026: System Glitch Disrupts Exam at Abuja CBT Center
-
International2 days agoSouth Korea Successfully Navigates First Oil Tanker Through Red Sea Amid Strait of Hormuz Blockade
-
Business2 days agoCBN introduces money market instrument NOFR
-
Crime2 days agoNDLEA jails 11 drug kingpins to 254 years in prison
-
Business2 days agoMAN Condemns World Bank’s Call for Nigeria PMS imports
-
News2 days agoArise TV Deputy Director News Win Editor of The Year Award
